The aim of this study is to collect data on activity, toxicity and quality of life of
trabectedin therapy in patients with recurrent high-grade meningioma.
Phase:
Phase 2
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC